Published in Front Mol Neurosci on April 13, 2016
Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy. Neurochem Res (2017) 0.76
Pore-Forming Proteins as Mediators of Novel Epigenetic Mechanism of Epilepsy. Front Neurol (2017) 0.75
Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches. Front Mol Neurosci (2017) 0.75
Epigenetic determinants of space radiation-induced cognitive dysfunction. Sci Rep (2017) 0.75
Adenosine Kinase Inhibition Protects against Cranial Radiation-Induced Cognitive Dysfunction. Front Mol Neurosci (2016) 0.75
Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity. J Neurosci (2016) 0.75
Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy. Pharmacol Ther (2017) 0.75
Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science (2009) 5.24
Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci (2010) 5.12
Benzodiazepine receptor: demonstration in the central nervous system. Science (1977) 3.92
The role of inflammation in epilepsy. Nat Rev Neurol (2010) 3.89
Organic compound synthesis on the primitive earth. Science (1959) 3.68
2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci (2006) 3.36
Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci (2004) 2.25
Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J Neurosci (2008) 2.18
Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol (1992) 2.11
Role of S-adenosylhomocysteine in adenosinemediated toxicity in cultured mouse T lymphoma cells. Cell (1977) 2.09
Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest (2008) 1.86
Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron (2003) 1.84
A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors. J Clin Invest (2011) 1.79
The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol (2007) 1.72
Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci U S A (2002) 1.70
Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci (2005) 1.68
Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev (2010) 1.68
Silk polymer-based adenosine release: therapeutic potential for epilepsy. Biomaterials (2008) 1.57
Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain (2005) 1.51
Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain (2007) 1.50
Glia and epilepsy: excitability and inflammation. Trends Neurosci (2013) 1.49
Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci U S A (2001) 1.47
Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr (2002) 1.47
Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience (2002) 1.41
Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia (2003) 1.38
Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain. Cereb Cortex (2005) 1.37
Astrocyte dysfunction in epilepsy. Brain Res Rev (2009) 1.35
Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics (2013) 1.29
Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci U S A (2004) 1.27
Adenosine kinase: exploitation for therapeutic gain. Pharmacol Rev (2013) 1.26
Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol (2011) 1.24
Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors. Curr Top Med Chem (2005) 1.24
Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J Neurosci (2006) 1.23
Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol (2007) 1.23
Mechanism of synthesis of adenine from hydrogen cyanide under possible primitive earth conditions. Nature (1961) 1.20
Downregulation of hippocampal adenosine kinase after focal ischemia as potential endogenous neuroprotective mechanism. J Cereb Blood Flow Metab (2007) 1.18
Antiepileptic effects of silk-polymer based adenosine release in kindled rats. Exp Neurol (2009) 1.18
Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol (2013) 1.18
Glycinergic tonic inhibition of hippocampal neurons with depolarizing GABAergic transmission elicits histopathological signs of temporal lobe epilepsy. J Cell Mol Med (2008) 1.18
The course of cellular alterations associated with the development of spontaneous seizures after status epilepticus. Prog Brain Res (2002) 1.17
Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies. Epilepsy Res (2009) 1.17
Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain. Neurobiol Aging (2013) 1.15
Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function. Am J Hum Genet (2011) 1.14
Adenosine dysfunction in epilepsy. Glia (2011) 1.14
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency. Nat Neurosci (2005) 1.12
Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis (2010) 1.11
Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J Clin Invest (2013) 1.09
Astrocyte immune responses in epilepsy. Glia (2012) 1.09
Glycine transporters: essential regulators of synaptic transmission. Biochem Soc Trans (2006) 1.08
The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis? Epilepsia (2011) 1.07
Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J Neuropathol Exp Neurol (2009) 1.07
Changes in neural network homeostasis trigger neuropsychiatric symptoms. J Clin Invest (2014) 1.06
Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion. Trends Pharmacol Sci (2005) 1.05
Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. Brain (2014) 1.04
Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice. J Physiol (2005) 1.04
Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Biochem Pharmacol (2009) 1.03
Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy. Neuropharmacology (2011) 1.02
Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology (Berl) (2008) 1.02
Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy. Epilepsia (2011) 1.01
Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy. J Mol Neurosci (2011) 1.00
Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: evidence from genetically modified mouse models and pharmacological inhibition. Biochem Pharmacol (2011) 0.98
Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery (1997) 0.97
Focally injected adenosine prevents seizures in the rat. Exp Neurol (2004) 0.95
The emerging role of DNA methylation in epileptogenesis. Epilepsia (2012) 0.95
The glycine transporter 1 inhibitor SSR504734 enhances working memory performance in a continuous delayed alternation task in C57BL/6 mice. Psychopharmacology (Berl) (2008) 0.93
Regulation of cognition and symptoms of psychosis: focus on GABA(A) receptors and glycine transporter 1. Pharmacol Biochem Behav (2008) 0.93
Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis? Glia (2011) 0.91
Glycine transport inhibitors in the treatment of schizophrenia. Handb Exp Pharmacol (2012) 0.91
Presynaptic glycine receptors on hippocampal mossy fibers. Biochem Biophys Res Commun (2010) 0.89
Epigenetics and Epilepsy. Cold Spring Harb Perspect Med (2015) 0.88
Age-related changes of glycine receptor at the rat hippocampus: from the embryo to the adult. J Neurochem (2011) 0.88
Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats. Epilepsia (2005) 0.87
Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms. Neurotherapeutics (2013) 0.86
Epileptogenesis: can the science of epigenetics give us answers? Epilepsy Curr (2012) 0.85
Glial adenosine kinase--a neuropathological marker of the epileptic brain. Neurochem Int (2013) 0.84
Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures. Epilepsia (2010) 0.84
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.83
Adenosine and seizure termination. Ann Neurol (1991) 0.82
Origin of Life. Science (1959) 0.82
Glycine N-methyltransferase expression in the hippocampus and its role in neurogenesis and cognitive performance. Hippocampus (2014) 0.80
Comorbidities in Neurology: Is adenosine the common link? Neuropharmacology (2015) 0.80
Glycine transporter 1 is a target for the treatment of epilepsy. Neuropharmacology (2015) 0.80
Protective effect of adenosine receptor agonists in a new model of epilepsy--seizures evoked by mitochondrial toxin, 3-nitropropionic acid, in mice. Neurosci Lett (2001) 0.79
Activation of glycine receptors modulates spontaneous epileptiform activity in the immature rat hippocampus. J Physiol (2014) 0.78
Homeostatic control of brain function - new approaches to understand epileptogenesis. Front Cell Neurosci (2013) 0.81
Dynamic Regulation of the Adenosine Kinase Gene during Early Postnatal Brain Development and Maturation. Front Mol Neurosci (2016) 0.75